Home
About
FAQ
History (6)
Genetic risk assessment of type 2 diabetes-associated polymorphisms in African Americans.
Receptor, Muscarinic M3
Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab.
Volumetric splenic injury measurement in ct scans for comparison with injury score.
Conversion to positive tuberculosis test during etanercept treatment of psoriasis.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Conversion to positive tuberculosis test during etanercept treatment of psoriasis.
Sumner W, Feldman SR. Conversion to positive tuberculosis test during etanercept treatment of psoriasis. J Drugs Dermatol. 2007 Oct; 6(10):1048.
View in:
PubMed
subject areas
Humans
Immunoglobulin G
Immunologic Factors
Male
Middle Aged
Psoriasis
Receptors, Tumor Necrosis Factor
Tuberculin Test
Tuberculosis
Tumor Necrosis Factor-alpha
authors with profiles
Steven R. Feldman MD, PhD